Just two months after telegraphing plans to lay off 641 staffers at two of its Massachusetts sites, Takeda is parting ways ...

The world’s first injectable immune checkpoint inhibitor likely won’t make it to the U.S. anytime soon after the ...

Even as the BIOSECURE Act charts an uncertain path through the legislative process, the draft bill has already seriously ...

Which companies do Americans associate most with weight loss medication? If you answered Eli Lilly or Novo Nordisk, think ...

As Korean CDMO giant Samsung Biologics continues to ink production pacts around the globe, the company has added another ...

Under federal law, former FDA employees are prohibited from engaging in certain lobbying activities—but an investigation ...

With four contract modifications totaling more than $250 million, the government is leveling up its agreements with long-time ...

In yet another legal development surrounding counterfeit HIV drugs, a Florida court has handed down an indictment for the ...

In an unconventional move, Novartis recently said it will propose Giovanni Caforio, M.D., who recently stepped down as ...

Pfizer has hired a new oncology commercialization leader to help the business reach its goal of marketing eight blockbuster ...

As the November U.S. elections near, it's clear that drug pricing will remain an important topic for voters and politicians.

In a major win for Johnson & Johnson and Legend Biotech, their star CAR-T therapy Carvykti showed it can prolong the lives of ...